<bill session="107" type="h" number="1063" updated="2013-07-14T18:57:21-04:00">
  <state datetime="2001-03-15">REFERRED</state>
  <status>
    <introduced datetime="2001-03-15"/>
  </status>
  <introduced datetime="2001-03-15"/>
  <titles>
    <title as="introduced" type="short">Drug Competition Act of 2001</title>
    <title as="introduced" type="official">To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.</title>
  </titles>
  <sponsor id="400008"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2001-03-15">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2001-03-15">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2001-03-15">
      <text>Referred to House Judiciary</text>
    </action>
    <action datetime="2001-03-22">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSJU" name="House Judiciary" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Commerce"/>
    <term name="Actions and defenses"/>
    <term name="Administrative procedure"/>
    <term name="Antitrust law"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Federal Trade Commission"/>
    <term name="Fines (Penalties)"/>
    <term name="Generic drugs"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Health"/>
    <term name="Independent regulatory commissions"/>
    <term name="Injunctions"/>
    <term name="Law"/>
    <term name="Marketing"/>
    <term name="Pharmaceutical research"/>
    <term name="Research and development"/>
    <term name="Restrictive trade practices"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>3/15/2001--Introduced.
Drug Competition Act of 2001 - Requires brand name drug manufacturers and generic drug manufacturers to notify the Federal Trade Commission and the Attorney General of agreements regarding the sale or manufacture of generic drugs which could have the effect of limiting the research, development, manufacture, marketing, or selling of a generic drug product.</summary>
</bill>
